Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00595894 · ClinicalTrials.gov registry record
Rheumatoid Arthritis Comorbidity: Bone Health in Men and African Americans
A clinical trial, sponsored by University of Nebraska.
- Completed
- Registry status
- 1,745
- Enrollment target
NCT00595894: Completed study, sponsored by University of Nebraska.
NCT00595894 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 1,745 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00595894 has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 1,745 participants
- Enrollment target
Study Summary
The objective of the proposed study is to assess bone health and determinants of bone health among select subpopulations of rheumatoid arthritis patients.
Primary Outcome
Bone mineral density (BMD) test measures calcium and other minerals in bone. Bones containing more minerals are denser, so they tend to be stronger and less likely to break.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,745 participants |
| Start Date | 2004-07-01 |
| Est. Completion | 2013-01-01 |
What the finished NCT00595894 record still lists
NCT00595894 is an observational study that tracks outcomes without assigning an intervention. Its 1,745 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00595894 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00595894 about?
NCT00595894 is a clinical study titled "Rheumatoid Arthritis Comorbidity: Bone Health in Men and African Americans". The objective of the proposed study is to assess bone health and determinants of bone health among select subpopulations of rheumatoid arthritis patients.
What is the current status of trial NCT00595894?
This trial is currently completed. The enrollment target is 1,745 participants. The study started on 2004-07-01. Estimated completion is 2013-01-01.
Who is sponsoring clinical trial NCT00595894?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05934487 · 1,750 participants · NA
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- NCT06954337 · 1,750 participants · NA
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
- NCT07183527 · 1,750 participants · NA
Hybrid Type I Effectiveness-implementation Cluster Randomized Controlled Trial of CARES
- NCT04712656 · 1,739 participants
Effects of CPAP Therapy on Blood Pressure and Heart Rate Variability in Obstructive Sleep Apnea
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI